NASDAQ Biotechnology Index (NBI) Companies by Market Cap
The NASDAQ Biotechnology Index (NBI) tracks 263 constituent companies with a combined market cap of $1.67 Trillion, covering the largest publicly traded companies in USA. This ranking lists all NBI index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$1.67 Trillion
Constituent Companies
263
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 151 |
Amphastar P
NASDAQ:AMPH |
% | $959.02 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $21.88 | -0.36% |
| 152 |
Fortrea Holdings Inc.
NASDAQ:FTRE |
% | $948.95 Million | Healthcare | Biotechnology | $12.18 | +5.91% |
| 153 |
Phathom Pharmaceuticals Inc
NASDAQ:PHAT |
% | $936.94 Million | Healthcare | Biotechnology | $12.01 | +7.23% |
| 154 |
ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBP |
% | $902.41 Million | Healthcare | Biotechnology | $29.99 | -3.54% |
| 155 |
MannKind Corp
NASDAQ:MNKD |
% | $872.08 Million | Healthcare | Biotechnology | $2.84 | +0.35% |
| 156 |
Theravance Biopharma Inc
NASDAQ:TBPH |
% | $854.78 Million | Healthcare | Biotechnology | $16.79 | +0.30% |
| 157 |
Omeros Corporation
NASDAQ:OMER |
% | $851.51 Million | Healthcare | Biotechnology | $15.06 | +3.15% |
| 158 |
Arbutus Biopharma Corp
NASDAQ:ABUS |
% | $840.56 Million | Healthcare | Biotechnology | $4.32 | +2.86% |
| 159 |
Annexon Inc
NASDAQ:ANNX |
% | $833.22 Million | Healthcare | Biotechnology | $5.75 | -2.04% |
| 160 |
Sana Biotechnology Inc
NASDAQ:SANA |
% | $832.62 Million | Healthcare | Biotechnology | $3.27 | -0.61% |
| 161 |
Xencor Inc
NASDAQ:XNCR |
% | $827.65 Million | Healthcare | Biotechnology | $12.69 | +6.37% |
| 162 |
Kalvista Pharmaceuticals Inc
NASDAQ:KALV |
% | $820.37 Million | Healthcare | Biotechnology | $26.65 | -0.04% |
| 163 |
ARS Pharmaceuticals, Inc
NASDAQ:SPRY |
% | $813.24 Million | Healthcare | Biotechnology | $8.56 | +3.63% |
| 164 |
Janux Therapeutics Inc
NASDAQ:JANX |
% | $790.34 Million | Healthcare | Biotechnology | $14.34 | -0.21% |
| 165 |
Compass Pathways Plc
NASDAQ:CMPS |
% | $782.13 Million | Healthcare | Medical Care Facilities | $9.01 | -0.55% |
| 166 |
Kura Oncology Inc
NASDAQ:KURA |
% | $774.65 Million | Healthcare | Biotechnology | $8.77 | -0.68% |
| 167 |
MeiraGTx Holdings PLC
NASDAQ:MGTX |
% | $760.71 Million | Healthcare | Biotechnology | $9.41 | +2.06% |
| 168 |
Esperion Therapeutics Inc
NASDAQ:ESPR |
% | $726.75 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $3.11 | +55.50% |
| 169 |
Castle Biosciences Inc
NASDAQ:CSTL |
% | $724.17 Million | Healthcare | Diagnostics & Research | $24.81 | +1.31% |
| 170 |
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD |
% | $722.29 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $4.44 | +7.64% |
| 171 |
Astria Therapeutics Inc
NASDAQ:ATXS |
% | $718.13 Million | Healthcare | Biotechnology | $5873.65 | +10.87% |
| 172 |
Cullinan Oncology LLC
NASDAQ:CGEM |
% | $706.55 Million | Healthcare | Biotechnology | $13.43 | +2.91% |
| 173 |
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX |
% | $690.60 Million | Healthcare | Biotechnology | $1.63 | +1.24% |
| 174 |
Arvinas Inc
NASDAQ:ARVN |
% | $672.23 Million | Healthcare | Biotechnology | $10.51 | +6.16% |
| 175 |
CorMedix Inc
NASDAQ:CRMD |
% | $597.22 Million | Healthcare | Biotechnology | $7.79 | +2.64% |
| 176 |
Prime Medicine, Inc. Common Stock
NASDAQ:PRME |
% | $595.69 Million | Healthcare | Biotechnology | $3.41 | -3.81% |
| 177 |
Sage Therapeutics Inc
NASDAQ:SAGE |
% | $544.94 Million | Healthcare | Biotechnology | $8.68 | +0.00% |
| 178 |
Maravai Lifesciences Holdings Inc
NASDAQ:MRVI |
% | $540.93 Million | Healthcare | Biotechnology | $3.73 | +1.36% |
| 179 |
Rigel Pharmaceuticals Inc
NASDAQ:RIGL |
% | $525.38 Million | Healthcare | Biotechnology | $29.40 | +1.73% |
| 180 |
Zevra Therapeutics Inc.
NASDAQ:ZVRA |
% | $516.25 Million | Healthcare | Biotechnology | $10.07 | -0.98% |
| 181 |
Personalis Inc
NASDAQ:PSNL |
% | $513.29 Million | Healthcare | Diagnostics & Research | $5.78 | +4.71% |
| 182 |
Aquestive Therapeutics Inc
NASDAQ:AQST |
% | $512.41 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $4.20 | +2.44% |
| 183 |
Lyell Immunopharma Inc
NASDAQ:LYEL |
% | $485.93 Million | Healthcare | Biotechnology | $20.83 | +5.58% |
| 184 |
Prothena Corporation plc
NASDAQ:PRTA |
% | $482.32 Million | Healthcare | Biotechnology | $10.64 | -3.80% |
| 185 |
Solid Biosciences LLC
NASDAQ:SLDB |
% | $482.26 Million | Healthcare | Biotechnology | $7.13 | -1.79% |
| 186 |
4D Molecular Therapeutics Inc
NASDAQ:FDMT |
% | $464.06 Million | Healthcare | Biotechnology | $9.09 | +2.48% |
| 187 |
Iteos Therapeutics Inc
NASDAQ:ITOS |
% | $448.68 Million | Healthcare | Biotechnology | $10.15 | +0.00% |
| 188 |
Atea Pharmaceuticals Inc
NASDAQ:AVIR |
% | $444.57 Million | Healthcare | Biotechnology | $5.58 | +1.27% |
| 189 |
Pacific Biosciences of California
NASDAQ:PACB |
% | $443.94 Million | Healthcare | Medical Devices | $1.60 | +0.63% |
| 190 |
Kyverna Therapeutics, Inc. Common Stock
NASDAQ:KYTX |
% | $432.74 Million | Healthcare | Biotechnology | $8.87 | +0.80% |
| 191 |
Design Therapeutics Inc
NASDAQ:DSGN |
% | $430.65 Million | Healthcare | Biotechnology | $13.30 | -2.21% |
| 192 |
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO |
% | $421.14 Million | Healthcare | Biotechnology | $5.77 | +1.32% |
| 193 |
Neumora Therapeutics, Inc.
NASDAQ:NMRA |
% | $414.65 Million | Healthcare | Biotechnology | $2.44 | -1.21% |
| 194 |
Larimar Therapeutics Inc
NASDAQ:LRMR |
% | $408.15 Million | Healthcare | Biotechnology | $3.94 | -2.96% |
| 195 |
Enanta Pharmaceuticals Inc
NASDAQ:ENTA |
% | $404.82 Million | Healthcare | Biotechnology | $14.35 | +3.31% |
| 196 |
Allogene Therapeutics Inc
NASDAQ:ALLO |
% | $404.51 Million | Healthcare | Biotechnology | $2.15 | +0.94% |
| 197 |
Regenxbio Inc
NASDAQ:RGNX |
% | $404.48 Million | Healthcare | Biotechnology | $9.12 | +1.67% |
| 198 |
Entrada Therapeutics Inc
NASDAQ:TRDA |
% | $403.21 Million | Healthcare | Biotechnology | $14.50 | +7.41% |
| 199 |
Y mAbs Therapeutics
NASDAQ:YMAB |
% | $391.22 Million | Healthcare | Biotechnology | $8.61 | +0.23% |
| 200 |
Autolus Therapeutics Ltd
NASDAQ:AUTL |
% | $388.57 Million | Healthcare | Biotechnology | $1.47 | +4.26% |
Complete list of all companies in the NBI index ranked by market capitalization. Track index constituent performance and market values. View all indices